Lio, Peter A. http://orcid.org/0000-0001-7600-0152
Armstrong, April
Gutermuth, Jan
Nosbaum, Audrey
Sofen, Howard
Gil, Esther Garcia
Casillas, Marta
Chen, Sherry
Sun, Luna
Pierce, Evangeline
Elmaraghy, Hany
Dawson, Zach
Torres, Tiago
Clinical trials referenced in this document:
Documents that mention this clinical trial
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
https://doi.org/10.1007/s13555-024-01199-9
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
https://doi.org/10.1007/s13555-024-01158-4
Article History
Received: 29 February 2024
Accepted: 31 May 2024
First Online: 26 June 2024
Declarations
:
: Peter A. Lio has received grants as an investigator, honoraria for lecturing, and/or consulting fees from AbbVie, Arcutis, Almirall, Alphyn, Amyris, ASLAN, AOBiome, Bristol-Myers Squibb, Castle Biosciences, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Hyphens Pharma, Incyte, Janssen, LEO Pharma, La Roche-Posay, Merck, Micreos, Pfizer, Pierre-Fabre, Regeneron/Sanofi-Genzyme, and UCB. April Armstrong has received research grants from AbbVie, BMS, Dermira, Janssen, Kyowa Hakko Kirin, Lilly, Novartis, and UCB; and has received personal fees from AbbVie, BI/Parexel, BMS, Celgene, Dermavant, Genentech, GSK, Janssen, Lilly, Menlo Therapeutics, Merck, Modernizing Medicine, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Science 37, Sun Pharma, and Valeant. Jan Gutermuth received research grants and/or served as advisor/speaker for Janssen, Sanofi, LEO Pharma, Mylan, Lilly, Abbvie, and Pfizer. Howard Sofen has served as a clinical investigator for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen, Leo Pharma, Novartis, and Sun Pharma. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, and UCB. Esther Garcia Gil. is an employee of Almirall. Marta Casillas, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Zach Dawson are employees and shareholders of Eli Lilly and Company. All authors meet the International Committee of Medical Journal Editors criteria for authorship for this article and have given their approval for this version to be published.
: Informed consent was obtained from all patients before study procedures were initiated. For patients considered to be minors, the written consent of the parent or legal guardian, as well as the assent of the minor, was obtained. Both studies were conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The studies were approved by the appropriate institutional review boards or ethics committee situated across the 100 study sites in the USA, Canada, Europe, and the Asia/Pacific area.